STAT November 12, 2024
Ed Silverman

J&J argues the U.S. Health Resources and Services Administration wrongfully interpreted federal law

Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some hospitals that participate in a federal drug discount program.

In its lawsuit, the company argued the U.S. Health Resources...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Health System / Hospital, Pharma, Pharma / Biotech, Provider
National Pharmacists Day: Drug Topics’ Pharmacist Interviews from the Past Year
Personalized Medicine in GI Cancer: Transforming Treatment With Technology, Lifestyle Insights
STAT+: Biogen CEO confirms he’s shopping for biotechs: ‘We will be doing deals’
Our Sleep, Brain Aging, and Waste Clearance
Tune raises $175M for hepatitis B medicine, epigenetic research

Share This Article